Convergence Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Convergence Investment Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-16,491	Closed	-$877K	–	289
2020 Q3	$877K	Buy	16,491 +138	+0.8%	+$8.22K	0.31%	120
2020 Q2	$953K	Sell	16,353 -526	-3%	-$28.3K	0.33%	108
2020 Q1	$665K	Buy	+16,879	New	+$987K	0.29%	111
2019 Q4	–	Sell	-2,756	Closed	-$147K	–	328
2019 Q3	$147K	Buy	+2,756	New	+$141K	0.04%	255
2019 Q2	–	Sell	-5,947	Closed	-$308K	–	398
2019 Q1	$308K	Buy	+5,947	New	+$288K	0.07%	219
2016 Q3	–	Sell	-42,720	Closed	-$1.63M	–	398
2016 Q2	$1.63M	Sell	42,720 -48,136	-53%	-$2.11M	0.22%	170
2016 Q1	$3.74M	Buy	+90,856	New	+$3.74M	0.45%	82

Other funds holding SYNH

Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return

THLTP

Thomas H. Lee (THL) Partners Boston, Massachusetts $205M AUM 1.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

Convergence Investment Partners's SYNH Position: Q4 2020 in Review

Convergence Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2020, closing a stake of 16,491 shares — an estimated $877K sold.

Convergence Investment Partners first reported a position in SYNH in Q1 2016 and held it in 7 quarters. The position peaked at $3.74M in Q1 2016. 313 funds tracked by Wall St. Rank hold SYNH as of Q4 2020.

Convergence Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
Convergence Investment Partners sold 16,491 Syneos Health, Inc. Class A Common Stock shares in Q4 2020, an estimated $877K.
Convergence Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2016 and held it in 7 quarters.
Convergence Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $3.74M in Q1 2016.
313 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2020.

Based on Convergence Investment Partners's 13F filing for Q4 2020, filed 5 Feb 2021.